Literature DB >> 21171944

3D-QSAR study on a series of Bcl-2 protein inhibitors using comparative molecular field analysis.

Xuben Hou1, Jintong Du, Hao Fang, Minyong Li.   

Abstract

In this manuscript, three-dimensional quantitative structure-activity relationship (3D-QSAR) studies using comparative molecule field analysis (CoMFA) techniques were applied to provide the structural information of Bcl-2 inhibitors. The CoMFA model obtained from the training set were all statistically significant with the cross-validated coefficients (q(2)) of 0.568 and conventional coefficients (r(2)) of 0.991. The contribution of steric field and the electrostatic field is 0.635 and 0.365, respectively. The 3D-QSAR model was furthermore validated by a test set of 6 molecules. The predicted correlation coefficient (r(2)(pred)) on the test set is 0.582. Therefore, the 3D-QSAR models built may be used to exhibit the necessary ligand-based structural environment as well as to design novel Bcl-2 inhibitors with increasing activities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21171944     DOI: 10.2174/092986611794927992

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  4 in total

1.  Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.

Authors:  Ying Ma; Shu-Qing Wang; Wei-Ren Xu; Run-Ling Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

2.  Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines.

Authors:  Harinder Singh; Rahul Kumar; Sandeep Singh; Kumardeep Chaudhary; Ankur Gautam; Gajendra P S Raghava
Journal:  BMC Cancer       Date:  2016-02-09       Impact factor: 4.430

3.  Developing an effective polarizable bond method for small molecules with application to optimized molecular docking.

Authors:  Guanfu Duan; Changge Ji; John Z H Zhang
Journal:  RSC Adv       Date:  2020-04-20       Impact factor: 4.036

4.  Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.

Authors:  Lei Liu; Ying Ma; Run-Ling Wang; Wei-Ren Xu; Shu-Qing Wang; Kuo-Chen Chou
Journal:  Drug Des Devel Ther       Date:  2013-04-08       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.